Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
With a dynamic healthcare network and prominent medical research centers, Miami carries out a range of clinical trials. Leading institutions such as the University of Miami Miller School of Medicine, Mount Sinai Medical Center, Sylvester Comprehensive Cancer Center, and Baptist Health South Florida are at the forefront of groundbreaking research.
These organizations are deeply involved in pioneering studies across various medical fields, making Miami, Florida a prime destination for advancing clinical research and innovative treatments.
Why choose Miami for clinical trials?
Miami offers distinct advantages for participation in clinical trials. The city’s diverse population provides a broad spectrum of participants, enhancing the accuracy and applicability of research findings. Miami is renowned for its vibrant research environment and a focus on groundbreaking medical advancements across various fields.
By participating in a clinical trial in Miami, participants contribute to crucial medical research and benefit from the city’s top-tier research institutions and supportive clinical research infrastructure. This city not only provides access to innovative treatments but also supports significant progress in medical science and patient care.
Common conditions studied in Miami
In Miami, clinical trials encompass a wide range of medical conditions and diseases, reflecting the city’s diverse healthcare research landscape.
Cancer
Miami’s leading institutions, such as the Sylvester Comprehensive Cancer Center and the University of Miami Miller School of Medicine, conduct trials on various cancers, including breast, prostate, lung, pancreatic, and colorectal. These studies often explore innovative treatments like immunotherapies, targeted therapies, personalized medicine, and novel drug combinations.
Oncology trials in Miami also often explore novel drug combinations, gene therapies, and cutting-edge technologies to enhance treatment efficacy and patient outcomes. Cancer clinical trials are particularly important in Miami due to the city's high cancer incidence rates and its diverse population, which allows for broader and more inclusive research.
Cardiovascular Disease
In Miami, cardiovascular clinical trials focus on conditions like heart failure, coronary artery disease, atrial fibrillation, and hypertension. Research includes evaluating new medications, advanced medical devices, minimally invasive procedures, and innovative treatment strategies aimed at improving cardiovascular health and outcomes.
Clinical trials in Miami often involve evaluating novel anticoagulants, cutting-edge heart pump technologies, and regenerative medicine approaches like stem cell therapy. Cardiovascular clinical trials are particularly crucial in Miami due to the city’s high prevalence of cardiovascular disease, influenced by risk factors such as a high rate of obesity, high blood pressure, and diabetes.
Neurological disorders
Clinical trials in Miami investigate neurological conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis (MS). Neurological clinical trials are especially critical in Miami due to the city's growing elderly population, which is at higher risk for neurodegenerative conditions.
Studies often involve cutting-edge therapies including new drug treatments, advanced neurostimulation techniques, deep brain stimulation, and innovative approaches like gene therapy and regenerative medicine.
Diabetes and endocrine disorders
Clinical trials for diabetes and endocrine diseases in Miami are focused on conditions such as Type 1 and Type 2 diabetes, metabolic syndrome, thyroid disorders, and polycystic ovary syndrome (PCOS).
Major research institutions like the University of Miami Miller School of Medicine, Mount Sinai Medical Center, and Baptist Health South Florida are conducting trials on innovative treatments including new insulin formulations, continuous glucose monitoring systems, and advanced drug therapies targeting glucose metabolism and hormone regulation.
Autoimmune diseases
With a diverse population offering a broad patient base and a high incidence of autoimmune disorders, Miami researchers are consistently exploring treatments for autoimmune conditions like rheumatoid arthritis, multiple sclerosis (MS), inflammatory bowel disease, and lupus.
Trials here typically investigate new biologics, targeted therapies, immunomodulatory drugs, and other advanced therapies. The city’s renowned research centers, combined with a commitment to advancing treatment options, make Miami a pivotal hub for autoimmune disease research.
Respiratory diseases
Trials for respiratory conditions such as asthma, chronic obstructive pulmonary disorder (COPD), cystic fibrosis, and pulmonary fibrosis are prevalent in Miami. It’s thought this is due to the high rates of these conditions from influences such as environmental factors and high rates of smoking.
Leading research institutions, including the University of Miami Miller School of Medicine, Mount Sinai Medical Center, and Baptist Health South Florida, are investigating advanced therapies like novel inhaled medications, biologics targeting specific inflammatory pathways, and innovative drug delivery systems, as well as disease management strategies.
Infectious diseases
Miami’s clinical research landscape also addresses infectious diseases, including HIV, hepatitis, tuberculosis, and emerging viral infections such as Zika and COVID-19. Major institutions like the University of Miami Miller School of Medicine, the Miami VA Healthcare System, and Mount Sinai Medical Center are conducting trials on new antiviral drugs, vaccines, and treatment protocols.
As a major travel hub with a diverse, international population, clinical research teams have placed an emphasis on infectious disease trials to support the high rates of these conditions locally.
Local regulations and guidelines
Clinical trials are governed by a comprehensive set of regulations to ensure ethical conduct and participant safety. Federal oversight by the FDA mandates compliance with Good Clinical Practice (GCP) standards and approval of investigational new drugs and devices. Institutional Review Boards (IRBs) at local research institutions review and approve study protocols, ensuring ethical practices and informed consent.
Trials must also adhere to HIPAA regulations for privacy and confidentiality. While federal regulations are primary, state-specific laws in Florida and institutional policies at major centers like the University of Miami Miller School of Medicine and Mount Sinai Medical Center further ensure rigorous oversight and adherence to high research standards.
Benefits of participating in clinical trials
Participating in a clinical trial offers the unique advantage of accessing innovative treatments and therapies before they are broadly available. Participants receive the highest levels of care from expert healthcare professionals, who provide detailed monitoring and tailored support throughout the study.
Additionally, involvement in clinical trials is crucial for advancing medical research, potentially leading to significant breakthroughs in treatment options. By joining a trial, individuals not only access cutting-edge medical solutions but also contribute to the advancement of science, helping to shape future healthcare improvements for others.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
How to enroll in a clinical trial in Miami
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.